← Back to Search

Trauma-Informed Toolkit for HIV Prevention in African American Women

N/A

Waitlist Available

Led By Tiara C. Willie, PhD

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Non-English speaking

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 8-months after toolkit implementation in each clinic

Awards & highlights

No Placebo-Only Group

Summary

This trial seeks to develop a toolkit to increase pre-exposure prophylaxis uptake among African American women in the south who experience high rates of intimate partner violence.

Who is the study for?

This trial is for African American women receiving care at community healthcare clinics in Mississippi, who are at risk for HIV infection and may also be dealing with intimate partner violence. Participants must speak and understand English.

What is being tested?

The study is testing a Trauma-Informed Toolkit designed to increase the use of Pre-Exposure Prophylaxis (PrEP) among African American women. It aims to address both HIV prevention and intimate partner violence within two clinics in Jackson, Mississippi.

What are the potential side effects?

Since this trial involves the implementation of an educational toolkit rather than a medical intervention, there are no direct side effects from medications or treatments being studied.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 8-months after toolkit implementation in each clinic

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 8-months after toolkit implementation in each clinic

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 8-months after toolkit implementation in each clinic for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Pre-Exposure Prophylaxis

Secondary study objectives

Clinic's %Pre-Exposure Prophylaxis Uptake

Clinic's Pre-Exposure Prophylaxis Coverage

Clinic's proportion of women with Pre-Exposure Prophylaxis retention

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Trauma-Informed Pre-Exposure Prophylaxis Implementation ToolkitExperimental Treatment1 Intervention

The Toolkit to be developed in the proposed study includes components from the women-specific Pre-Exposure Prophylaxis care continuum theoretical model and implementation challenges, and is adapted to identify and provide care to women experiencing intimate partner violence. Overall, the Toolkit is designed to create culturally-congruent, intimate partner violence-informed clinical settings; and equip clinical staff with the knowledge and skills they need to address HIV prevention for African American women; and integrate intimate partner violence into Pre-Exposure Prophylaxis care services.

0 / 1Eligibility criteria met